ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/10/30 | 2,343 | 2,347 | 2,316 | 2,326 | +4 | +0.2% | 283,300 |
| 2024/10/29 | 2,308 | 2,339 | 2,300 | 2,322 | +14 | +0.6% | 50,300 |
| 2024/10/28 | 2,288 | 2,318 | 2,287 | 2,308 | +20 | +0.9% | 31,600 |
| 2024/10/25 | 2,319 | 2,319 | 2,276 | 2,288 | -26 | -1.1% | 39,600 |
| 2024/10/24 | 2,302 | 2,323 | 2,292 | 2,314 | +2 | +0.1% | 37,500 |
| 2024/10/23 | 2,305 | 2,326 | 2,303 | 2,312 | +1 | ±0% | 36,500 |
| 2024/10/22 | 2,326 | 2,337 | 2,311 | 2,311 | -15 | -0.6% | 39,200 |
| 2024/10/21 | 2,360 | 2,360 | 2,326 | 2,326 | -22 | -0.9% | 27,800 |
| 2024/10/18 | 2,333 | 2,354 | 2,326 | 2,348 | +23 | +1% | 32,500 |
| 2024/10/17 | 2,360 | 2,369 | 2,321 | 2,325 | -30 | -1.3% | 38,400 |
| 2024/10/16 | 2,340 | 2,369 | 2,337 | 2,355 | +5 | +0.2% | 47,700 |
| 2024/10/15 | 2,357 | 2,357 | 2,335 | 2,350 | +11 | +0.5% | 44,500 |
| 2024/10/11 | 2,360 | 2,361 | 2,329 | 2,339 | -18 | -0.8% | 49,300 |
| 2024/10/10 | 2,350 | 2,357 | 2,331 | 2,357 | +20 | +0.9% | 34,300 |
| 2024/10/09 | 2,350 | 2,360 | 2,331 | 2,337 | -5 | -0.2% | 55,900 |
| 2024/10/08 | 2,323 | 2,348 | 2,314 | 2,342 | +4 | +0.2% | 60,200 |
| 2024/10/07 | 2,340 | 2,354 | 2,322 | 2,338 | +14 | +0.6% | 60,800 |
| 2024/10/04 | 2,314 | 2,338 | 2,314 | 2,324 | +17 | +0.7% | 61,600 |
| 2024/10/03 | 2,310 | 2,314 | 2,292 | 2,307 | +32 | +1.4% | 52,300 |
| 2024/10/02 | 2,284 | 2,310 | 2,264 | 2,275 | -8 | -0.4% | 71,600 |
| 2024/10/01 | 2,253 | 2,283 | 2,240 | 2,283 | +13 | +0.6% | 54,000 |
| 2024/09/30 | 2,228 | 2,271 | 2,222 | 2,270 | +14 | +0.6% | 85,800 |
| 2024/09/27 | 2,228 | 2,268 | 2,218 | 2,256 | -7 | -0.3% | 82,600 |
| 2024/09/26 | 2,241 | 2,273 | 2,236 | 2,263 | +27 | +1.2% | 250,500 |
| 2024/09/25 | 2,228 | 2,244 | 2,220 | 2,236 | +6 | +0.3% | 108,900 |
| 2024/09/24 | 2,253 | 2,261 | 2,230 | 2,230 | -17 | -0.8% | 119,800 |
| 2024/09/20 | 2,244 | 2,267 | 2,224 | 2,247 | +24 | +1.1% | 133,500 |
| 2024/09/19 | 2,249 | 2,257 | 2,212 | 2,223 | -14 | -0.6% | 98,600 |
| 2024/09/18 | 2,216 | 2,238 | 2,215 | 2,237 | +23 | +1% | 62,800 |
| 2024/09/17 | 2,203 | 2,216 | 2,186 | 2,214 | +21 | +1% | 75,800 |
| 2024/09/13 | 2,208 | 2,222 | 2,181 | 2,193 | -39 | -1.7% | 73,000 |
| 2024/09/12 | 2,235 | 2,257 | 2,223 | 2,232 | +22 | +1% | 53,300 |
| 2024/09/11 | 2,250 | 2,250 | 2,201 | 2,210 | -54 | -2.4% | 52,700 |
| 2024/09/10 | 2,265 | 2,285 | 2,257 | 2,264 | -1 | ±0% | 41,700 |
| 2024/09/09 | 2,234 | 2,270 | 2,225 | 2,265 | +13 | +0.6% | 61,400 |
| 2024/09/06 | 2,263 | 2,278 | 2,246 | 2,252 | +1 | ±0% | 44,700 |
| 2024/09/05 | 2,226 | 2,265 | 2,224 | 2,251 | +7 | +0.3% | 59,700 |
| 2024/09/04 | 2,229 | 2,269 | 2,224 | 2,244 | -15 | -0.7% | 76,000 |
| 2024/09/03 | 2,263 | 2,273 | 2,242 | 2,259 | +16 | +0.7% | 48,800 |
| 2024/09/02 | 2,301 | 2,301 | 2,230 | 2,243 | -68 | -2.9% | 79,000 |
| 2024/08/30 | 2,285 | 2,324 | 2,280 | 2,311 | +41 | +1.8% | 109,900 |
| 2024/08/29 | 2,275 | 2,284 | 2,262 | 2,270 | -8 | -0.4% | 36,100 |
| 2024/08/28 | 2,292 | 2,296 | 2,263 | 2,278 | -5 | -0.2% | 29,700 |
| 2024/08/27 | 2,289 | 2,299 | 2,281 | 2,283 | +1 | ±0% | 29,800 |
| 2024/08/26 | 2,272 | 2,283 | 2,257 | 2,282 | +8 | +0.4% | 37,100 |
| 2024/08/23 | 2,269 | 2,285 | 2,255 | 2,274 | +27 | +1.2% | 69,100 |
| 2024/08/22 | 2,224 | 2,256 | 2,224 | 2,247 | +39 | +1.8% | 50,900 |
| 2024/08/21 | 2,200 | 2,223 | 2,200 | 2,208 | -9 | -0.4% | 25,400 |
| 2024/08/20 | 2,200 | 2,225 | 2,194 | 2,217 | +28 | +1.3% | 40,600 |
| 2024/08/19 | 2,184 | 2,203 | 2,181 | 2,189 | -11 | -0.5% | 28,400 |
151～
200
件表示中 / 3720件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 202,700円 | +3.1% | -6.5% | 2.37% | 9.41倍 | 0.99倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 科研薬 | 386,400円 | -6.4% | -71.8% | 4.92% | 43.03倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 300,000円 | +7.9% | -3.3% | 2.67% | 8.34倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| 持田薬 | 295,200円 | +5.1% | -7.0% | 2.71% | 19.38倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 148,600円 | -2.4% | -52.3% | 3.84% | 17.79倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
